Monoclonal Antibody Therapy NOW Available at NRMC

Understanding the Facts: Dr. Phyllis Mason, Chief Medical Officer

Monoclonal Antibody Therapy administered to COVID positive patient who may be at a higher risk of hospitalization due to their risk factors has proven to be highly successful. We encourage anyone who is COVID positive and has never been hospitalized for COVID-19, to speak with their primary care provider to see if they are a candidate for MAT.